An article in the August issue of Healthcare Risk Management, “DOJ Targeting Healthcare for False Claims Act Enforcement,” discussed recent enforcement activity by the U.S. Department of Justice (DOJ) under the False Claims Act (FCA). Rivkin Radler’s Jeff Kaiser was quoted in the article.
Jeff predicted that the FCA will continue to be vigorously enforced and its application will be even further expanded. Fraud involving the Medicare Advantage program will continue to be a focus.
Jeff added, “DOJ will also continue to use the FCA to prosecute cybersecurity fraud and pandemic relief fraud. However, the Trump administration also has expressed an intention to expand FCA enforcement to new areas, including prosecution of efforts to avoid custom and tariff obligations, false certifications of compliance with civil rights laws (including through diversity, equity, and inclusion programs that unlawfully discriminate), and the submission of false claims for non-covered transgender-related medical services.”
